Reuters explains how SpaceX’s upcoming IPO uses a dual‑class share structure that gives Musk ten votes per share, preserving his decision‑making power. While supporters claim it shields visionary founders from short‑term pressure, critics warn it concentrates authority and weakens corporate accountability.
The article outlines seven tactics elite sales leaders use to retain high‑performing reps, from fast promotions and market‑competitive compensation to giving them AI copilots and involving them in product changes. It stresses security, culture, and building structures around top talent to prevent turnover as markets evolve.
ClickUp announced a 22% workforce reduction while deploying roughly 3,000 internal AI agents to handle tasks, promising higher salaries for those who harness the technology. CEO Zeb Evans says the shift will boost productivity and turn the firm into a “100x org,” signaling a new model where employees direct AI rather than perform work themselves.
Brad Feld highlights the mental‑health debt founders face and spotlights Meru Health’s new Advanced program, which bundles psychiatry, therapy, nutrition, sleep, exercise, social support, and substance‑use care into one coordinated, data‑driven plan. The holistic approach aims to give founders the continuous health monitoring elite athletes enjoy.
Brad Feld reviews Theo Baker’s memoir ‘How to Rule the World,’ revealing how powerful institutions, like Stanford’s board, dismiss inconvenient reporting and mishandle crises. The book serves as a master‑class in what not to do when confronting scandal, offering lessons for leaders on ethics, crisis response, and the influence of venture capital culture.
The old HR metric of “Would you hire them again?” is becoming obsolete as affordable AI agents can handle 60‑80% of knowledge work. SaaStr outlines a three‑step test, clarify outcomes, gauge agent capability, and evaluate the remaining human value, showing its own shift to agents lifted revenue from, 19% to +47% YoY.
John Gruber reports that Y Combinator, through its YC Research arm, retains an equity stake in OpenAI. Because Sam Altman was YC’s president before becoming OpenAI’s CEO, he may indirectly benefit from that stake, sparking conflict‑of‑interest and trust concerns. The exact size of YC’s holding remains unclear.